Heat-shock protein 65 as a beta cell antigen of insulin-dependent diabetes

D B Jones1, N R Hunter, G W Duff

  • 1Department of Medicine, Western General Hospital, Edinburgh, UK.

Lancet (London, England)
|September 8, 1990
PubMed

Insights

Heat-shock protein 65 (HSP65) from Mycobacterium tuberculosis may be the primary beta-cell antigen in insulin-dependent diabetes. Autoimmunity to HSP65 might increase susceptibility to this autoimmune disease.

Area of Science:

  • Immunology
  • Endocrinology
  • Microbiology

Background:

  • The primary beta-cell antigen in insulin-dependent diabetes is a ~64 kD protein.
  • Insulinoma cells synthesize this 64 kD protein upon stimulation with hyperthermia and cytokines like interleukin-1 beta, gamma interferon, and tumor necrosis factor.

Purpose of the Study:

  • To investigate the identity of the 64 kD beta-cell antigen.
  • To explore the potential role of heat-shock proteins in the pathogenesis of insulin-dependent diabetes.

Main Methods:

  • Western blot analysis was used to assess cross-reactivity between the 64 kD beta-cell protein and antibodies against heat-shock protein 65 (HSP65) from Mycobacterium tuberculosis and Mycobacterium leprae.
  • Inhibition assays were performed using serum from insulin-dependent diabetic patients.

Main Results:

  • Cross-reactivity was observed between the 64 kD beta-cell protein and antibodies against Mycobacterium tuberculosis HSP65, but not against Mycobacterium leprae HSP65.
  • Serum from insulin-dependent diabetic patients, containing antibodies to the 64 kD beta-cell antigen, inhibited the binding of Mycobacterium tuberculosis HSP65 antibodies to cytokine-treated cells.

Conclusions:

  • Heat-shock protein 65 (HSP65) is suggested to be the 64 kD beta-cell antigen.
  • Autoreactivity to an epitope of HSP65 may confer susceptibility to insulin-dependent diabetes mellitus.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...